showed that oxidative stress is involved in the etiology of diabetes-induced down-regulation of heart function via depressed endogenous antioxidant defense mechanisms.
INTRODUCTION
Cardiac dysfunction, independent of arteriosclerosis, is one of complications in diabetes mellitus, and diabetic cardiomyopathy causes a wide range of structural and functional abnormalities (21, 27 ] i in the myocardium is a critical determinant of contractile performance, current controversies and conclusions are available regarding the specific alterations in Ca 2+ signaling pathways to contribute to these cardiac defects during diabetes mellitus (30, 48). Thus, the molecular mechanisms of cardiac dysfunction in diabetes are not fully clarified.
Reactive oxygen species (ROS) are continuously produced in most cells under physiological conditions, and a number of enzymes and physiological antioxidants regulate their levels.
Evidence implicates hyperglycemia-derived oxygen free radicals and disregulation of nitric oxide (NO) as mediators of diabetic complications (6, 9, 43). However, as the production of ROS becomes excessive, oxidative stress and nitrosative stress will develop causing functional alterations of biological tissue and are implicated in the pathogenesis of heart failure in diabetes (12, 23, 32, 50) . A number of ways have been suggested in which, the damaging effect of hyperglycemia can be mediated or enhanced by ROS. For instance, hyperglycemia stimulates the production of advanced glycosylated products, and enhances the polyol pathway leading to increased superoxide anion formation (49, 55), and degrade antioxidant enzyme defenses, thereby allowing ROS to damage other enzymes and structural proteins (11, 12). 4 Although there is no direct data related with alteration of concentration and distribution of ] i in diabetic rat heart.
METHODS

Experimental procedures
Wistar rats of both sexes (weighing 200-220 g) were housed separately according to their groups in a room with controlled temperature and humidity, with a 12-h light -12-h dark period and received food and tap water ad libitum throughout the experiment. The rats were randomly divided into four groups. In the control group, the vehicle, 0.1 M citrate buffer (pH:
4.5) used to dissolve streptozotocin (STZ) was intraperitoneally (ip) injected (0.2 ml) once to all rats. Some of the control group rats were treated with sodium selenite (5 µmol/kg body weight/day, ip; named treated control group) while some of them were treated with 0.1 ml volume of sodium selenite vehicle (distilled water) for 4-weeks (untreated control group).
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Diabetes was induced by a single injection of STZ (50 mg/kg body weight, ip). A week after injection of STZ, blood glucose levels were measured and rats with blood glucose at least three times higher than the pre-injection levels were used in the experiments. Once the presence of diabetes was confirmed, diabetic rats were randomly separated into two groups:
Untreated diabetic group (rats injected with 0.1 ml distilled water) and treated diabetic group (rats injected with sodium selenite as an amount of 50 mg/kg body weight) for 4-weeks.
Plasma glucose level of all animals was measured using a glucose analyzer (Glucotrend, Roche). Plasma selenium levels were measured by using graphite-furnace atomic absorption spectrometry (AA-30/40 Varian atomic absorption spectrometer equipped with a GTA-96
Graphite Tube Atomizer, DS-15 Data Station). Plasma zinc levels were measured colorimetrically.
Isolation of cardiomyocytes
Hearts were removed rapidly and aorta was cannulated on a Langendorff apparatus, and then Total glutathione measurement is based on a chemical reaction, which proceeds in two steps.
The first step leads to the formation of substitution products (thioethers) between a patented reagent, R1 (4-chloro-1-methyl-7-trifluromethyl-quinolinium methylsulfate), and all mercaptans (RSH), which are present in the sample. The second step is -elimination reaction, which takes place under alkaline conditions. This reaction is mediated by reagent R2 (30% NaOH) which specifically transforms the substitution product (thioether) obtained with GSH into a chromophoric thione, which has a maximal absorbance wavelength at 400 nm. 
Reduced glutathione (GSH)
Chemicals and statistical evaluation of data
All chemicals used were purchased from Sigma (Sigma-Aldrich Chemie, Steinheim, Germany) except for fura-2 AM, which was purchased from Molecular Probes (Eugene, OR, USA) and collagenase A that was purchased from Boehringer Manheim (Roche Diagnostics, Manheim, Germany). Two groups were compared using student t-test. P values <0.05 were taken as significant. Data presented as average ± SEM, throughout the text.
RESULTS
General characteristics of the animals
Sodium selenite treatment did affect weight gain in the treated controls compared neither with the untreated controls nor in the treated diabetics compared with the untreated diabetics, significantly (Fig. 1) . The average body weight was significantly lower in diabetic rats compared with the control rats at 5-weeks following to the STZ injection (Table 1) .
Moreover, sodium selenite treatment could prevent deleterious weight loss seen in untreated diabetic rats. Sodium selenite treatment caused a small but significant increase in blood glucose level (p<0.05 vs untreated control group). Treatment of the diabetic animals with sodium selenite did decrease high blood glucose level with a small but significant (p<0.05) level compared with untreated diabetic group.
Following first week of STZ injection, 24% diabetic rats did die during 4-weeks experimental period. This value was 20% in sodium selenite treated diabetic group. On the other hand,
there was no lost in number of either untreated or treated control groups. Neither diabetes nor 4 weeks sodium selenite treatment of these rats could induce any change in both plasma selenium and zinc levels significantly ( Table 1) . We determined intracellular R min and R max,Zn values using the protocol illustrated in Fig. 2A . For R max,Zn the myocytes were exposed to the zinc ionophore Zn-pyrithione (1 µM). The resulting increase in fluorescence ratio reached a steady-state maximum value of 1.07 ± 0.01 (n = 19) after 5 min, representing the highest ratio that can be elicited by saturating concentrations of intracellular free Zn 2+ ( Fig. 2A, right) . As shown in the (Fig. 2C) .
Measurement of intracellular free
Effect of sodium selenite treatment and diabetes on Ca 2+ transients
The effects of sodium selenite treatment of rats and diabetes in the presence of normal extracellular Ca 2+ (1.8 mM) on electrically field-stimulated cardiomyocytes were also examined. Figure 3 illustrates the effect of diabetes and sodium selenite treatment of both diabetic and control rats on fluorescence ratios recorded from cardiomyocytes superfused with 1.8 mM Ca 2+ and stimulated under field effect without TPEN exposure. As can be seen from the original traces of this figure (part A), the amplitude as well as the kinetic parameters of the traces from diabetic cardiomyocytes are significantly different from the controls. These two traces are put together in the same scale for comparison. The average value of the amplitude of Ca 2+ transients recorded from diabetic rat cardiomyocytes is significantly smaller than the control (Fig. 3B) . Both time to peak (TP; Fig. 3C ) and half decay time (DT 50 ; Fig. 3D ) of Ca 2+ transients of cardiomyocytes isolated from diabetic rats are significantly slower than the controls. As can be seen from these bar graphs, sodium selenite treatment of diabetic rats can cause a complete restoration in the amplitude and a significant effect on prolonged DT 50 while no significant effect on prolonged TP. On the other hand, sodium selenite treatment of the control rats for four weeks has no significant effects on these measured parameters.
To be able to test a possible interference of Zn 2+ transients under field stimulation, we exposed the cells to TPEN and then measured all the parameters mentioned the previous section. The average values were put in Table 2 . As can be seen from these data (comparison with the data in Fig. 3 ), there are no Zn 2+ transients under field stimulation (Fig. 3A, left 
Effect of sodium selenite treatment on diabetes-induced oxidant stress in heart
Malondialdehyde (MDA) content, which is indicative of lipid peroxidation, increased significantly in the diabetic rat heart with respect to the control group. Sodium selenite treatment of the rats caused a complete normalization in the diabetic group while no effect in the control group (Fig. 4A) . We also measured nitric oxide products (NOPs), which is indicative of oxidant stress in the cell. NOPs level increased significantly in diabetic rat heart tissue and sodium selenite treatment of these diabetic rats prevented this increase significantly while no significant effect on the control rats (Fig. 4B ).
Both superoxide dismutases (SOD) and glutathione reductase (GR) activities are depressed significantly in the diabetic rat hearts while glutathione peroxidase (GSHPx) activity increased. These three different enzymes activities, which play important roles in the antioxidant defense system in the cell, were normalized with sodium selenite treatment ( Figure 5A , B, and C, respectively).
Diabetes induced a significant reduction in reduced glutathione (GSH) and increase in oxidized glutathione (GSSG) contents in cardiac tissue with respect to the control group (Table 3) . Treatment of the diabetic rats with sodium selenite for four weeks caused a significant attenuation in the GSH/GSSG ratio, which is a good estimation of the redox state as well as oxidative stress. The treatment of the rats from the control group with the same amount of sodium selenite surprisingly has small but significant effect on this ratio (Table 3) .
Effect of sodium selenite treatment on heart metallothionein level
We measured an antioxidant protein metallothionein (MT) level, which is a cysteine-rich protein, and can bind heavy ion such as zinc, and has a strong effect in scavenging free radicals, in heart tissue. As can be seen from Table 3 , diabetes can induce a significant decrease in MT levels and sodium selenite treatment of the diabetic rats can prevent this decrease and normalize to the control level. The treatment of the normal rats with sodium selenite has no significant effect on MT level of the heart tissue.
DISCUSSION
One of major findings of the present study is that diabetes induced a significant increase in ] i might have important contribution to defects in contractile activity. In addition, the present data showed that diabetes could induce and/ or cause oxidant stress, and therefore, mobilization of Zn 2+ from intracellular stores might contribute to oxidant-induced alterations of excitation-contraction coupling in diabetic rat heart. This hypothesis has support from previously published data. Zn 2+ is highly likely that any mechanism, that alters its concentration and distribution, will cause profound functional effects in cardiomyocytes.
Metallothionein and increase basal [Zn
2+
] i . Our data showed that metallothionein (MT) level of diabetic rat heart is significantly reduced whereas basal ] i , which can cause dysfunctions in cells system even if in the level of gene expression and apoptosis (1, 35) . Therefore, these are pointing out the importance of our present data in the defense mechanisms of the heart in diabetes. Is the beneficial effect of selenium due to its insulin mimetic effect in STZ-induced diabetic rats? The mechanisms of sodium selenite-mediated normalization of altered mechanical and electrical activities of diabetic rat heart are not fully understood at this time. However, our 21 hypothesis of antioxidant effect via glutathione involvement is supported by recent studies.
Beneficial effect selenium on increased basal [Zn
These studies demonstrated that exogenous application of glutathione and other antioxidants such as SOD, catalase, or their mimetic compounds protected the heart of diabetic rats via insulin-signaling cascade (6, 9, 17, 18, 37, 43, 62, 63). Therefore, it is quite tempting to suggest the possible roles of this signaling pathway in controlling the intracellular redox state and the normal function of cardiac myocytes. Therefore, previously published data offers further insight into the mechanisms at play in this model. Under in vitro conditions, it has been shown that sodium selenate treatment of adiposities could increase glucose uptake and phosphorylation, as well as the activity of several signaling proteins, that are normally activated with insulin (20, 28, 54). Thus, when evaluating the published data with the present findings, it seems likely that sodium selenite treatment affects the diabetes-induced heart dysfunction through its effect on cell GSH, which is, in turn, closely related with the insulinsignaling cascade.
Moreover, sodium selenite administration to the normal rats caused a slight but significant increase in blood glucose level, and a significant decrease in plasma insulin level. Previously we have also shown some important alterations in the kinetics of Ca 2+ -and K + -currents due to the effect of selenium on insulin-signaling cascade via alterations in the cell redox status (4). Although there is no direct data, some authors showed that either external or internal application of GSSG leads to changes in ionic channels to be related with altered GSSG levels and coupled to insulin-signaling cascade (22, 34, 37). Therefore, under these implications, our data showed that sodium selenite can affect some functions of normal rats via a change in cellular GSH level due to increased blood glucose level and decreased plasma insulin level. Additional studies are needed whether small doses of selenium compounds may be useful and/or prooxidant when they are used as supplements in normal human diets.
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In conclusion, all above observations demonstrates the current controversies in this subject, but it is clear that the impaired contractility of the intact diabetic hearts can be due to defects in cellular Ca 2+ metabolisms of individual cardiomyocyte. It can be concluded that there is lack of complete clarification in the molecular mechanisms of the cardiac dysfunction in diabetes and needed further studies. Specifications of the groups are given in the legend of Table 1 . Student t-test was used, * p <0.001 vs untreated control group, # < 0.01 vs untreated diabetic group. 
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